Mallinckrodt Pharmaceuticals
MNK
#10252
Rank
NZ$8.07 M
Marketcap
$0.61
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Mallinckrodt Pharmaceuticals (MNK)

EPS in 2023 (TTM): -$199.64

According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$216.33. In 2021 the company made an earnings per share (EPS) of -$15.13 an increase over its 2020 EPS that were of -$19.99.

EPS history for Mallinckrodt Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$199.64
2021-$15.13-24.31%
2020-$19.99-5.41%
2019-$21.14-72.67%
2018-$77.35-291.46%
2017$40.40797.22%
2016$4.50-34.03%
2015$6.83-207.61%
2014-$6.34-366.73%
2013$2.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$25.17-111.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.57-98.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$15.28-107.06%๐Ÿ‡บ๐Ÿ‡ธ USA